EyeBio raises $65m in Series A round: ‘Our goal is to build a broad and diverse pipeline of therapies for the eye’ 28-Feb-2022 By Jane Byrne Eyebiotech Limited, which was only founded in August last year, has just completed a successful US$65m Series A funding round.